Sign In
17 Apr 2009 15:47
17th April 2009
REGEN THERAPEUTICS PLC
("ReGen" or the "Company"; Ticker: (RGT))
TR-1(i): NOTIFICATION OF MAJOR INTEREST IN SHARES
Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):
ReGen Therapeutics Plc
2. Reason for the notification:
An event changing the break down of voting rights
3. Full name of person(s) subject to the notification obligation (iii):
Barclays PLC
4. Full name of shareholder(s) (if difference from 3):
Barclays Stockbrokers Ltd
5. Date of the transaction and date on which the threshold is crossed or reached (v):
15th April 2009
6. Date on which issued notified:
17th April 2009
7. Threshold(s) that is/are crossed or reached:
11% to 10%
8. Notified details
A: Voting rights attached to shares
Class/type of share if possible using the ISIN Code GB00B28XMY25 Situation Previous to the triggering transaction (vi) – Number of Shares 2,465,917 Number of Voting Rights (viii) 2,465,917 Resulting situation after the triggering transaction (viii) – Number of Shares 2,465,917 Number of Voting Rights – Direct (x) N/A Number of Voting Rights – Indirect (xi) 2,465,917 % of voting rights – Direct N/A % of voting rights – Indirect 10.85 B: Financial Instruments Resulting situation after the triggering transaction (xii) Type of financial instrument N/A Expiration date (xiii) N/A Exercise/Conversion Period/Date (xiv) N/A Number of voting rights that may be acquired if the instrument is exercised/converted N/A % of voting rights N/A Total (A+B) Number of voting rights 2,465,917 % of voting rights 10.85
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are
effectively held, if applicable (xv): Barclays Stockbrokers Ltd
Proxy Voting:
10. Name of the proxy holder: N/A
11. Number of voting rights proxy holder will cease to hold: N/A
12. Date on which proxy holder will cease to hold voting rights: N/A
13. Additional information: N/A
14. Contact name: Geoff Smith
15. Contact telephone number: 0207 116 2913
For further information:
For further information, please contact:Percy Lomax ReGen Therapeutics Plc Tel: 020 7153 4920Roland Cornish/Felicity Geidt Beaumont Cornish Limited Tel: 020 7628 3396
Follow the stocks
